Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label study of N-Acetyl-GED-0507-34-Levo 5% gel in acne vulgaris
ISRCTN49040930Phase 3Active, not recruiting
- Sponsor
- PPM Services
- Start
- Sep 2024
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of N-acetyl-GED-0507-34-LEVO in acne vulgaris, sponsored by PPM Services. Primary endpoints: Incidence of adverse events, Treatment discontinuation due to treatment-emergent adverse events and 5 more. Started Sep 2024; status: active, not recruiting.
02
Drugs
N-acetyl-GED-0507-34-LEVO
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on ISRCTN49040930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN49040930.